;,^D)6I*6O>,~~FWJ>B<%M:]'XSZR>H$WN#BJR^]!Z]%S$2
SYSTEM PROCESSING...
;,^D)6I*6O>,~~FWJ>B<%M:]'XSZR>H$WN#BJR^]!Z]%S$2
SYSTEM PROCESSING...
Posted: 2025-04-27 04:10:50 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-27 04:11:05 UTC
Verified By
Rollup News
The JACCCEP study demonstrates the first successful use of selective subclavian ansae stimulation (SAS) in humans, highlighting the SA as a potential target for autonomic neuromodulation therapy.
First successful application of selective subclavian ansae stimulation (SAS) in humans
SA as a potentially important site for targeted autonomic neuromodulation therapy